News | May 26, 2009

SenoRx to Deliver Three Studies at American Brachytherapy Society

May 26, 2009 - SenoRx will deliver three oral presentations summarizing clinical findings related to its Contura Multi-Lumen Balloon (MLB) Catheter at the American Brachytherapy Society (ABS) Annual Meeting being held May 31-June 2, 2009, in Toronto, Canada.

"The three scheduled presentations, along with other studies, continue to support our belief that a patient treated with Contura MLB can receive a more targeted dose of radiation, while minimizing radiation to healthy tissue such as the skin and ribs," said SenoRx President and CEO Lloyd Malchow.

Presentations to be delivered at the ABS conference are: "Initial Dosimetric Experience: Contura Multi-Lumen Balloon (MLB) Registry Trial," by Arthur, D.W.; Vicini, F.A.; Todor, D.; and Julian, T.B. The conclusion of this study is that without the dosimetric optimizing capabilities, the safe use of a single lumen balloon is limited to patients with ideal cavity geometry and balloon symmetry. This initial comparison shows that the use of multiple, off-set lumens allow the optimization of target coverage while minimizing dose to nearby skin and chest wall, thus creating a new improved dosimetric standard.

The other study is: "A Comparison of Skin and Chest Wall Dose Delivered with Multi-Catheter (MC), Contura Multi-Lumen Balloon (MLB), and MammoSite (MS) Breast Brachytherapy" by Cuttino, L.W.; Todor, D.T.; Heffernan, J.; Vera, R.; and Arthur, D.W. The conclusion of this study is that the multicatheter and Contura MLB techniques are associated with significantly lower mean skin and chest wall doses than with MammoSite, which was associated with significantly more patients receiving doses to these areas in excess of 125 percent of the prescription dose. Doses delivered with Contura MLB were more similar to those of the multi-catheter technique, which is associated with a very low incidence of skin and chest wall toxicity, suggesting treatment with Contura MLB may prove to be better tolerated.

The third study is titled, "Verification of Balloon Rotation for the Contura Multi-Lumen Device for Accelerated Partial Breast Irradiation," by Ouhib Z., Benda, R., Kasper, M., Vargas, C. This study’s conclusion says that the alignment of the skin mark with lumen number one can be a reliable tool to align the balloon prior to treatment and also that no internal device rotation or torquing is likely to occur. This is critical for the MLB as there may be significant variability in dwell times between catheters and various dwell points within a catheter to allow for skin and/or rib sparing while maintaining adequate dose coverage.

For more information: www.senorx.com

Related Content

Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Australia's Monash Cancer Centre Treats First Early-Stage Breast Cancer Patient With Xoft System
News | Brachytherapy Systems, Women's Healthcare | May 01, 2017
iCAD Inc. announced the first early-stage breast cancer patient was treated in Australia with intraoperative radiation...
New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting
News | Brachytherapy Systems, Women's Healthcare | April 20, 2017
iCAD Inc. announced that updated clinical data on the use of intraoperative radiation therapy (IORT) using the Xoft...
Concure Oncology, Breast Microseed Treatment, one day, low-dose rate brachytherapy, LDR
Technology | Brachytherapy Systems, Women's Healthcare | May 12, 2016
Concure Oncology/Breast Microseed Inc. announced the launch of its one-time, one-hour radiation treatment option for...
News | Brachytherapy Systems, Women's Healthcare | April 20, 2016
Cianna Medical Inc. announced new clinical data evaluating the Savi Scout breast localization and surgical guidance...
Gamma pro, kubtec
News | Breast Imaging | November 04, 2015
Kubtec announced the launch of the Gamma-Pro Node and Seed Location System for use in breast seed location and sentin
iCAD, Xoft Axxent, electronic brachytherapy, eBx, clinical studies, ASTRO 2015, radiation therapy

Xoft Axxent image courtesy of iCAD Inc.

News | Brachytherapy Systems | October 21, 2015
iCAD Inc. presented updated clinical data, hosted in-booth clinician presentations and showcased the latest in...
APBI, accelerated partial breast irradiation, multicatheter brachytherapy, breast conserving surgery, whole breast irradiation, WBI, ASTRO 2015
News | Brachytherapy Systems, Women's Healthcare | October 19, 2015
For some early-stage breast cancer patients, accelerated partial breast irradiation (APBI) using multicatheter...
Theragenics, Advanced Radiation Therapy LLC, AccuBoost, early stage breast cancer, brachytherapy
News | Brachytherapy Systems, Women's Healthcare | August 07, 2015
Theragenics Corp. has reached an agreement with Advanced Radiation Therapy LLC to distribute the AccuBoost technology...
Cianna Medical, SAVI Scout, breast surgical guidance system

Photo courtesy of Cianna Medical

Technology | December 16, 2014
Cianna Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for the SAVI Scout surgical guidance...
Overlay Init